Found: 49
Select item for more details and to access through your institution.
Longitudinal analysis of novel Alzheimer's disease proteomic cerebrospinal fluid biomarkers during intravenous immunoglobulin therapy.
- Published in:
- Electrophoresis, 2012, v. 33, n. 13, p. 1975, doi. 10.1002/elps.201100660
- By:
- Publication type:
- Article
Two Novel Psychomotor Tasks in Idiopathic Normal Pressure Hydrocephalus.
- Published in:
- Journal of the International Neuropsychological Society, 2016, v. 22, n. 3, p. 341, doi. 10.1017/S1355617715001125
- By:
- Publication type:
- Article
IN SESSION with Norman R. Relkin, MD, PhD.
- Published in:
- 2010
- By:
- Publication type:
- Interview
CURRENT STATE OF IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. Suppl. 6, p. 39
- By:
- Publication type:
- Article
A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 10, p. 1222, doi. 10.1016/j.jalz.2014.10.014
- By:
- Publication type:
- Article
Antibodies in the dimer fraction of IVIG have the capacity to bind beta amyloid
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P4-351: Effects of uninterrrupted intravenous immunoglobulin treatment of Alzheimer's disease for nine months
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P3-488: The impact of an education and risk evaluation protocol on perceived benefits and risks of genetic susceptibility testing for Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P3-081: Longitudinal analysis of antemortem cerebrospinal fluid in the assessment of Alzheimer's disease intravenous immunoglobulin immunotherapy
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-365: A method for measuring anti-beta amyloid (Aβ) oligomer antibodies in human plasma and intravenous iimmunoglobulin
- Published in:
- 2008
- By:
- Publication type:
- Abstract
S1-02-02: Natural human antibodies targeting amyloid aggregates in intravenous immunoglobulin
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O2-05-05: IVIg contains antibodies against oligomers and fibrils of beta amyloid
- Published in:
- 2007
- By:
- Publication type:
- Abstract
P-004: Incorporating ethnicity into genetic risk assessment for Alzheimer’s disease: The reveal study experience
- Published in:
- 2007
- By:
- Publication type:
- Abstract
P4-251: Decreased plasma beta amyloid levels in Alzheimer patients treated chronically with Intravenous immunoglobulin (IVIG)
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-201: Age group differences in response to genetic risk assessment: Results from the risk evaluation & education for Alzheimer’s disease (REVEAL) study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-165: MRI traits are heritable among Alzheimer disease cases and their siblings in the MIRAGE Study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-283: Ethnic differences in MRI scans among Alzheimer’s disease patients and unaffected siblings in the MIRAGE Study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-273: Extended versus condensed protocol for disclosing genetic susceptibility for Alzheimer’s disease: The REVEAL Study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O3-05-04: Intravenous immunoglobulin (IVIg) maintains cognition over 18 months in patients with Alzheimer’s disease (AD)
- Published in:
- 2006
- By:
- Publication type:
- Abstract
S3-04-06: Intravenous immunoglobulin (IVIg) therapy
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-251: Decreased plasma beta amyloid levels in Alzheimer patients treated chronically with Intravenous immunoglobulin (IVIG)
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-201: Age group differences in response to genetic risk assessment: Results from the risk evaluation & education for Alzheimer’s disease (REVEAL) study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-165: MRI traits are heritable among Alzheimer disease cases and their siblings in the MIRAGE Study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-283: Ethnic differences in MRI scans among Alzheimer’s disease patients and unaffected siblings in the MIRAGE Study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-273: Extended versus condensed protocol for disclosing genetic susceptibility for Alzheimer’s disease: The REVEAL Study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O3-05-04: Intravenous immunoglobulin (IVIg) maintains cognition over 18 months in patients with Alzheimer’s disease (AD)
- Published in:
- 2006
- By:
- Publication type:
- Abstract
S3-04-06: Intravenous immunoglobulin (IVIg) therapy
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Apolipoprotein E, Aβ-Amyloid, and the Molecular Pathology of Alzheimer's Disease Therapeutic Implicationsa.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 802, n. 1, p. 42, doi. 10.1111/j.1749-6632.1996.tb32597.x
- By:
- Publication type:
- Article
The National Institute on Aging/Alzheimer's Association Recommendations on the Application of Apolipoprotein E Genotyping to Alzheimer's Diseasea.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 802, n. 1, p. 149, doi. 10.1111/j.1749-6632.1996.tb32608.x
- By:
- Publication type:
- Article
Bibliography NIA/AlzA Conference on Apolipoprotein E Genotyping in Alzheimer's Disease.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 802, n. 1, p. 177, doi. 10.1111/j.1749-6632.1996.tb32609.x
- By:
- Publication type:
- Article
8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease.
- Published in:
- Proteomics, 2007, v. 7, n. 20, p. 3651, doi. 10.1002/pmic.200700316
- By:
- Publication type:
- Article
A Large, Community-Based, Open-Label Trial of Donepezil in the Treatment of Alzheimer's Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2003, v. 16, n. 1, p. 15, doi. 10.1159/000069988
- By:
- Publication type:
- Article
Genetic Risk Assessment for Adult Children of People With Alzheimer's Disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) Study.
- Published in:
- Journal of Geriatric Psychiatry & Neurology, 2005, v. 18, n. 4, p. 250, doi. 10.1177/0891988705281883
- By:
- Publication type:
- Article
Mental status testing in the elderly nursing home population.
- Published in:
- 1995
- By:
- Publication type:
- journal article
The immune system, amyloid-β peptide, and Alzheimer's disease.
- Published in:
- Immunological Reviews, 2005, v. 205, n. 1, p. 244, doi. 10.1111/j.0105-2896.2005.00264.x
- By:
- Publication type:
- Article
Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing.
- Published in:
- JAMA: Journal of the American Medical Association, 1997, v. 278, n. 2, p. 136, doi. 10.1001/jama.1997.03550020068040
- By:
- Publication type:
- Article
Reply: Cerebrospinal fluid proteomics for biomarkers of Alzheimer's disease.
- Published in:
- Annals of Neurology, 2007, v. 61, n. 5, p. 497, doi. 10.1002/ana.21126
- By:
- Publication type:
- Article
Development and Testing of a New Outcome Measure of Relationship Between Patients With Alzheimer's Disease and Their Partners.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2006, v. 21, n. 4, p. 249, doi. 10.1177/1533317506290665
- By:
- Publication type:
- Article
Visual Function and Brain Organization in Non-decussating Retinal-Fugal Fibre Syndrome.
- Published in:
- Cerebral Cortex, 2000, v. 10, n. 1, p. 2, doi. 10.1093/cercor/10.1.2
- By:
- Publication type:
- Article
An update on research priorities in hydrocephalus: overview of the third National Institutes of Health-sponsored symposium "Opportunities for Hydrocephalus Research: Pathways to Better Outcomes".
- Published in:
- Journal of Neurosurgery, 2015, v. 123, n. 6, p. 1427, doi. 10.3171/2014.12.JNS132352
- By:
- Publication type:
- Article
Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population.
- Published in:
- Annals of Neurology, 1999, v. 45, n. 1, p. 48, doi. 10.1002/1531-8249(199901)45:1<48::AID-ART9>3.0.CO;2-V
- By:
- Publication type:
- Article
Increased apolipoprotein E ϵ4 in epilepsy with senile plaques.
- Published in:
- Annals of Neurology, 1997, v. 41, n. 3, p. 402, doi. 10.1002/ana.410410317
- By:
- Publication type:
- Article
Apolipoprotein E ϵ4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica.
- Published in:
- Annals of Neurology, 1995, v. 38, n. 4, p. 698, doi. 10.1002/ana.410380429
- By:
- Publication type:
- Article
Generation and Regulation of β-Amyloid Peptide Variants by Neurons.
- Published in:
- Journal of Neurochemistry, 1998, v. 71, n. 5, p. 1920, doi. 10.1046/j.1471-4159.1998.71051920.x
- By:
- Publication type:
- Article
Distinct cortical areas associated with native and second languages.
- Published in:
- Nature, 1997, v. 388, n. 6638, p. 171, doi. 10.1038/40623
- By:
- Publication type:
- Article
Salmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14685-3
- By:
- Publication type:
- Article
A Pilot Study of Quantitative MRI Measurements of Ventricular Volume and Cortical Atrophy for the Differential Diagnosis of Normal Pressure Hydrocephalus.
- Published in:
- Neurology Research International, 2012, p. 1, doi. 10.1155/2012/718150
- By:
- Publication type:
- Article
Current state of immunotherapy for Alzheimer's disease.
- Published in:
- 2008
- By:
- Publication type:
- journal article
CURRENT STATE OF IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE.
- Published in:
- CNS Spectrums: The International Journal of Neuropsychiatric Medicine, 2008, v. 13, n. 10, p. 39, doi. 10.1017/S1092852900027061
- By:
- Publication type:
- Article